A Multi-Center, Double-Blind Randomized Controlled Phase III Clinical Trial to Evaluate the Antiviral Activity and Safety of DA-2802 (Tenofovir Disoproxil Orotate) and Viread (Tenofovir Disoproxil Fumarate) in Chronic Hepatitis B Patients | Zendy

Hyung Joon Kim | Zendy; Ju Hyun Kim | Zendy; Jong Eun Yeon | Zendy; Yeon Seok Seo | Zendy; Jeong Won Jang | Zendy; Yong Kyun Cho | Zendy; Byoung Kuk Jang | Zendy; Byung Hoon Han | Zendy; Changhyeong Lee | Zendy; Joon Hyeok Lee | Zendy; JungHwan Yoon | Zendy; Kang Mo Kim | Zendy; Moon Young Kim | Zendy; Do Young Kim | Zendy; Neung Hwa Park | Zendy; Eun Young Cho | Zendy; June Sung Lee | Zendy; JinWoo Lee | Zendy; In Hee Kim | Zendy; ByungCheol Song | Zendy; Byung Seok Lee | Zendy; Oh Sang Kwon | Zendy

Open Access

A Multi-Center, Double-Blind Randomized Controlled Phase III Clinical Trial to Evaluate the Antiviral Activity and Safety of DA-2802 (Tenofovir Disoproxil Orotate) and Viread (Tenofovir Disoproxil Fumarate) in Chronic Hepatitis B Patients

Author(s) -

Hyung Joon Kim,

Ju Hyun Kim,

Jong Eun Yeon,

Yeon Seok Seo,

Jeong Won Jang,

Yong Kyun Cho,

Byoung Kuk Jang,

Byung Hoon Han,

Changhyeong Lee,

Joon Hyeok Lee,

JungHwan Yoon,

Kang Mo Kim,

Moon Young Kim,

Do Young Kim,

Neung Hwa Park,

Eun Young Cho,

June Sung Lee,

JinWoo Lee,

In Hee Kim,

ByungCheol Song,

Byung Seok Lee,

Oh Sang Kwon

Publication year - 2022

Publication title -

journal of korean medical science

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.743

H-Index - 66

eISSN - 1598-6357

pISSN - 1011-8934

DOI - 10.3346/jkms.2022.37.e92

Subject(s) - medicine , hbeag , clinical endpoint , hbsag , adverse effect , hepatitis b virus , hepatitis b , gastroenterology , randomized controlled trial , dosing , virology , virus

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research